Biostar Pharmaceuticals Inc (BSPM)

Biostar Pharmaceuticals Inc is a common stock listing on OTC Markets for a healthcare company focused on pharmaceuticals. The company develops, manufactures, and markets medicines for a range of diseases and conditions in the People’s Republic of China. Its product portfolio includes both over-the-counter and prescription pharmaceutical products. Key OTC products mentioned in the source include Xin Ao Xing Oleanolic Acid capsules for chronic hepatitis B, as well as treatments used for symptoms related to colds, menstrual pain, chronic gastritis, joint pain, and cataracts. The company also sells prescription products such as Danshen granules, Piracetam tablets, Fosfomycin Calcium capsules, and Aspirin Enteric-coated tablets. Biostar Pharmaceuticals distributes its products through distributors and via an internet-based hospital platform that provides hepatitis B information and treatment-related purchasing access. The company was incorporated in 2007 and is headquartered in Xianyang, China.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.